Proteomics

Dataset Information

0

Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma


ABSTRACT: Aurora kinase A (AURKA) is a well-established target in neuroblastoma (NB) due to both its catalytic functions during mitosis and its kinase-independent functions, including stabilization of the key oncoprotein MYCN. We present a structure-activity relationship (SAR) study of MK-5108-derived PROTACs against AURKA by exploring different linker lengths and exit vectors on the thalidomide moiety. PROTAC SK2188 induces the most potent AURKA degradation (DC50,24h 3.9 nM, Dmax,24h 89%) and shows an excellent binding and degradation selectivity profile. Treatment of NGP neuroblastoma cells with SK2188 induced concomitant MYCN degradation, high replication stress/DNA damage levels and apoptosis. Moreover, SK2188 significantly outperforms the parent inhibitor MK-5108 in a cell proliferation screen and patient-derived organoids. Furthermore, altering the attachment point of the PEG linker to the 5-position of thalidomide allowed us to identify a potent AURKA degrader with a linker as short as 2 PEG units. With this, our SAR-study provides interesting lead structures for further optimization and validation of AURKA degradation as a potential therapeutic strategy in neuroblastoma.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell

SUBMITTER: Teresa Mendes Maia  

LAB HEAD: Kaat Durinck

PROVIDER: PXD040389 | Pride | 2023-02-27

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications


Aurora kinase A (AURKA) is a well-established target in neuroblastoma (NB) due to both its catalytic functions during mitosis and its kinase-independent functions, including stabilization of the key oncoprotein MYCN. We present a structure-activity relationship (SAR) study of MK-5108-derived PROTACs against AURKA by exploring different linker lengths and exit vectors on the thalidomide moiety. PROTAC SK2188 induces the most potent AURKA degradation (DC<sub>50,24h</sub> 3.9 nM, D<sub>max,24h</sub  ...[more]

Similar Datasets

2023-02-27 | PXD040391 | Pride
2024-09-03 | PXD050960 | Pride
2016-02-11 | E-GEOD-73008 | biostudies-arrayexpress
2012-10-05 | E-GEOD-37233 | biostudies-arrayexpress
2022-02-15 | PXD020738 | Pride
2022-05-27 | PXD032031 | Pride
2024-01-04 | PXD044171 | Pride
2016-01-13 | E-GEOD-76775 | biostudies-arrayexpress
2024-06-23 | PXD050629 | Pride
2016-03-18 | PXD002215 | Pride